← Evidence map

ArticleCancer diagnosis & prognosis

An Imaging Feature Predicts Efficacy of Atezolizumab Plus Bevacizumab in Unresectable Hepatocellular Carcinoma.

Akifumi Kuwano et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

4 papers cite it

2024
2025
2026
cites it
Full record →Abstract, authors, funding and every citing paper · PMID 37405218